Oscar Health Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
OSCR$33.47+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity
| Class A · Class B | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands) | Shares | Amount | Shares | Amount | Treasury Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interests | Total Stockholders' Equity |
| December 31, 2023 | 193,875 | $2 | 35,514 | $— | $(2,923) | $3,682,294 | $(2,876,715) | $1,309 | $2,150 | $806,117 |
| Issuance of common stock from equity incentive plans | 6,622 | — | — | — | — | 27,309 | — | — | — | 27,309 |
| Stock-based compensation expense | — | — | — | — | — | 27,282 | — | — | — | 27,282 |
| Unrealized gains (losses) on investments, net | — | — | — | — | — | — | — | (3,903) | — | (3,903) |
| Net Income | — | — | — | — | — | — | 177,368 | — | 114 | 177,482 |
| March 31, 2024 | 200,497 | $2 | 35,514 | $— | $(2,923) | $3,736,885 | $(2,699,347) | $(2,594) | $2,264 | $1,034,287 |
| Class A · Class B | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands) | Shares | Amount | Shares | Amount | Treasury Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interests | Total Stockholders' Equity |
| December 31, 2022 | 181,176 | $2 | 35,116 | $— | $(2,923) | $3,509,007 | $(2,605,987) | $(9,715) | $2,016 | $892,400 |
| Issuance of common stock from equity incentive plans | 2,057 | — | — | — | — | 35 | — | — | — | 35 |
| Stock-based compensation expense | — | — | — | — | — | 73,248 | — | — | — | 73,248 |
| Joint venture contributions | — | — | — | — | — | 471 | — | — | — | 471 |
| Unrealized gains (losses) on investments, net | — | — | — | — | — | — | — | 5,236 | — | 5,236 |
| Net loss | — | — | — | — | — | — | (39,772) | — | 144 | (39,628) |
| March 31, 2023 | 183,234 | $2 | 35,116 | $— | $(2,923) | $3,582,761 | $(2,645,759) | $(4,479) | $2,160 | $931,762 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.